Kristin Brooks01.02.14
Indegene, a provider of clinical and commercial solutions to global life science organizations, has acquired Total Therapeutic Management, Inc. (TTM), an Atlanta-based quality improvement, outcomes research, and clinician engagement services company, expanding its healthcare service portfolio. TTM provides services to large healthcare organizations, including the U.S. federal government, in the areas of academic detailing, HEDIS/STAR improvement, outcomes research, and medical record retrieval and review.
Dr. Rajesh Nair, president of Indegene, said, "Over the last 18 years, TTM has built significant expertise and experience in effectively utilizing sound clinical knowledge and engagement tactics to improve healthcare quality. This transaction expands Indegene Healthcare's presence in the commercial and federal healthcare markets and increases our quality solution portfolio. We are delighted to have the TTM team join us."
Ed Perez, Pharm.D., chief executive officer and co-founder of TTM, said, "We are delighted to be partnering with Indegene. This new phase will allow us to leverage Indegene's global, clinical and technology capabilities to further accelerate investments, and offer our clients a broader range of services from Indegene Healthcare's portfolio."
Dr. Rajesh Nair, president of Indegene, said, "Over the last 18 years, TTM has built significant expertise and experience in effectively utilizing sound clinical knowledge and engagement tactics to improve healthcare quality. This transaction expands Indegene Healthcare's presence in the commercial and federal healthcare markets and increases our quality solution portfolio. We are delighted to have the TTM team join us."
Ed Perez, Pharm.D., chief executive officer and co-founder of TTM, said, "We are delighted to be partnering with Indegene. This new phase will allow us to leverage Indegene's global, clinical and technology capabilities to further accelerate investments, and offer our clients a broader range of services from Indegene Healthcare's portfolio."